European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease

  • Email
  • Help

Details

TitleEuropean Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer's disease
Date24/11/2014 - 25/11/2014
LocationEuropean Medicines Agency, London, UK
SummaryThe Agency is organising this workshop following the public-consultation exercise on its concept paper on the need for revision of the guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias. The aim of the workshop is to make sure that, while revising its guideline, the EMA can take the most up-to-date scientific developments in understanding and treating Alzheimer’s disease into consideration, as well as the positions of experts in the field. Registration is open until 01/07/2014. Places limited.

All documents

Name Language First published Last updated
Programme of European Medicines Agency workshop on the clinical investigation of medicines for the treatment of Alzheimer’s disease (English only) 2014-11-19  
Discussion paper on the clinical investigation of medicines for the treatment of Alzheimer's disease and other dementias (English only) 2014-10-30 2014-11-20
Presentation - Subjective cognitive decline as the first symptom of Alzheimer’s disease (Frank Jessen) (English only) 2014-12-01  
Presentation - The latest advances in the understanding of the pathophysiology of Alzheimer’s disease and the development of disease-modifying therapies (Gary Romano) (English only) 2014-12-01  
Presentation - Changing diagnostic criteria for Alzheimer’s disease - impact on clinical trials (Bruno Dubois) (English only) 2014-12-01  
Presentation - The changing diagnostic criteria for Alzheimer's disease - regulatory challenges (Marion Haberkamp) (English only) 2014-12-01  
Presentation - Developing drugs for the treatment of Alzheimer’s disease (Eric Bastings, Billy Dunn) (English only) 2014-12-01  
Presentation - Novel regulatory sience research on drugs for Alzheimer's disease - a guideline on the clinical evaluation of drugs for Alzheimer’s disease (Interim report) (Takashi Moritoyo) (English only) 2014-12-01  
Presentation - The scientific and regulatory approaches to facilitating disease-modifying drug development and registration in a global environment (Thomas Blaettler) (English only) 2014-12-01  
Presentation - Global dementia integrated development (Raj Long) (English only) 2014-12-01  
Presentation - An approach to outcome measure development - a regulatory perspective (Elektra Papadopoulos) (English only) 2014-12-01  
Presentation - The choice of outcome parameters and need for distinct assessment tools with regard to the different disease stages in Alzheimer’s disease (Iva Holmerová) (English only) 2014-12-01  
Presentation - Accelerating drug development for Alzheimer’s disease through regulatory science (Martha Brumfield) (English only) 2014-12-01  
Presentation - Clinical outcome measures - an industry perspective (Veronika Logovinsky) (English only) 2014-12-01  
Presentation - The choice of outcome parameters and need for distinct assessment tools with regard to the different disease stages in Alzheimer's disease - regulator’s perspective (Jens Heisterberg) (English only) 2014-12-01  
Presentation - Potential use of biomarkers and their temporal relationship with the different phases of Alzheimer's disease in different stages of drug development (Olivier Blin) (English only) 2014-12-01  
Presentation - The potential use of biomarkers in Alzheimer’s disease in different stages of drug development (Johan Luthman) (English only) 2014-12-01  
Presentation - European Union regulatory perspective on the potential use of biomarkers in Alzheimer's disease drug development (Valentina Mantua) (English only) 2014-12-01  
Presentation - Drug development for behavioral and psychological symptoms of dementia in Japan (Akifumi Kamata) (English only) 2014-12-01  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms in Alzheimer's disease and other dementias - patient and carers' perspective (Mary-Frances Morris) (English only) 2014-12-01  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms - focus on challenges of the clinical diagnosis of Alzheimer's disease (Reinhold Schmidt) (English only) 2014-12-01  
Presentation - The place for treatments and trial design considerations for associated neuropsychiatric symptoms in Alzheimer's disease (Rachel Schindler) (English only) 2014-12-01  
Presentation - The place for treatments of associated neuropsychiatric and other symptoms (Luca Pani) (English only) 2014-12-01  
Presentation - The changing diagnostic criteria for Alzheimer's disease, including early and asymptomatic disease stages and their impact on clinical trial design (Eric Siemers) (English only) 2014-12-01  
Presentation - Disease modifying drug development - statistical design and analysis (David Brown) (English only) 2014-12-01  

Media Videos


Live broadcast

  • 24 November 2014
    9:30 - 17:30 UK time
  • 25 November 2014
    9:00 - 12:00 UK time

small format video Icon To watch the broadcast click on 'Multimedia' tab.

Video recording
A video recording will be made available after the event. 

To view use the ‘Multimedia’ tab.

Related information